Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy.

Front Immunol · 2022 · PMC9399602 · PMID 36032151

Europe PMC DOI

hedged sentence

0.0760

closest p · 1.5× alpha

0.0760

boldest claim

The sentences

showed a trendp = 0.076so close (0.05 < p ≤ 0.1)

Using X-tile method, we found that patients with a Kyn : Trp ratio less than 0.09 showed a trend for better OS (HR = 0.66, 95% CI, 0.40–1.110; p = 0.076; Figure 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.